Koji Nakamura Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

12/2019

Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Nakamura Research Topics

Disease

24	Neoplasms (Cancer) 11/2023 - 09/2009
15	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 01/2014
5	Pain (Aches) 01/2021 - 09/2007
5	Fibrosis (Cirrhosis) 11/2018 - 01/2016
4	Infections 06/2022 - 02/2005
4	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 01/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 12/2021
3	Atrophy 11/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 09/2018 - 07/2010
3	Inflammation (Inflammations) 01/2018 - 11/2013
2	COVID-19 07/2023 - 03/2023
2	Nephritis 01/2023 - 03/2022
2	Proteinuria 01/2023 - 03/2022
2	Glomerulonephritis 01/2023 - 03/2022
2	Carcinogenesis 01/2023 - 01/2016
2	Adenocarcinoma 01/2023 - 10/2017
2	Melanoma (Melanoma, Malignant) 03/2021 - 01/2020
2	Ovarian Epithelial Carcinoma 01/2019 - 11/2018
2	Neoplasm Metastasis (Metastasis) 05/2016 - 03/2012
2	Chorioamnionitis 03/2016 - 11/2013
1	Lupus Nephritis 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Genomic Instability 01/2023
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Cough 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Multiple Myeloma 05/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019
1	Cholangiocarcinoma 12/2019
1	Vasculitis (Vasculitides) 11/2018
1	Chronic Hepatitis C 05/2018
1	Fever (Fevers) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Vertigo (Positional Vertigo) 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 03/2021 - 01/2014
6	AntigensIBA 07/2023 - 01/2021
5	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 09/2022 - 08/2019
4	CytokinesIBA 03/2022 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 09/2018 - 01/2014
3	Monoclonal AntibodiesIBA 12/2019 - 09/2009
3	AS2553627IBA 11/2018 - 02/2017
3	Janus Kinase InhibitorsIBA 01/2018 - 01/2017
3	Phosphotransferases (Kinase)IBA 02/2017 - 03/2016
2	LigandsIBA 11/2023 - 01/2021
2	AntibodiesIBA 11/2023 - 03/2022
2	Programmed Cell Death 1 ReceptorIBA 11/2023 - 03/2022
2	Immunoglobulin G (IgG)IBA 10/2023 - 03/2022
2	Plasminogen Activator Inhibitor 1IBA 10/2023 - 10/2017
2	RNA (Ribonucleic Acid)IBA 10/2023 - 03/2021
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023 - 03/2022
2	cathepsin SIBA 01/2023 - 03/2022
2	Estrogens (Estrogen)FDA Link 01/2023 - 01/2018
2	AutoantibodiesIBA 03/2022 - 12/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 01/2019
2	LipidsIBA 08/2019 - 02/2015
2	Formaldehyde (Formol)FDA Link 02/2019 - 09/2007
2	VitronectinIBA 11/2018 - 10/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017 - 05/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 04/2015
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2015 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 01/2011
1	Bevacizumab (Avastin)FDA Link 10/2023
1	Poly I-CIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	CD3 ComplexIBA 09/2022
1	NivolumabIBA 03/2022
1	IpilimumabIBA 03/2022
1	B7-H1 AntigenIBA 03/2022
1	AutoantigensIBA 03/2022
1	Fc gamma receptor IIBIBA 01/2022
1	CateninsIBA 01/2022
1	Tadalafil (Cialis)FDA Link 01/2022
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	Bortezomib (Velcade)FDA Link 05/2020
1	Lenalidomide (CC 5013)FDA Link 05/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 12/2019
1	Nucleic AcidsIBA 08/2019
1	Analgesics (Analgesic Drugs)IBA 02/2019
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 02/2019
1	Culture MediaIBA 11/2018
1	Fibronectins (Fibronectin)IBA 11/2018
1	asunaprevirIBA 05/2018
1	daclatasvirIBA 05/2018
1	TNP-ficollIBA 01/2018
1	FicollIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018

Therapy/Procedure

14	Therapeutics 11/2023 - 07/2010
3	Aftercare (After-Treatment) 01/2018 - 01/2003
2	Immunotherapy 09/2022 - 03/2022
2	Transplantation 02/2017 - 01/2016
1	Oral Administration 03/2022
1	Radioimmunotherapy 01/2021
1	Intravenous Injections 12/2019